Ahmed et al., 2003 - Google Patents
An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serumAhmed et al., 2003
View PDF- Document ID
- 13778096010690475221
- Author
- Ahmed N
- Barker G
- Oliva K
- Garfin D
- Talmadge K
- Georgiou H
- Quinn M
- Rice G
- Publication year
- Publication venue
- Proteomics
External Links
Snippet
Proteomic technologies are being used to discover and identify disease‐associated biomarkers. The application of these technologies in the search for potential diagnostic/prognostic biomarkers in the serum of patients has been limited by the presence …
- 210000002966 Serum 0 title abstract description 82
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
- G01N33/6839—Total protein determination, e.g. albumin in urine involving dyes, e.g. Coomassie blue, bromcresol green
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ahmed et al. | An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum | |
Wang et al. | A simple affinity spin tube filter method for removing high‐abundant common proteins or enriching low‐abundant biomarkers for serum proteomic analysis | |
Granger et al. | Albumin depletion of human plasma also removes low abundance proteins including the cytokines | |
Mehta et al. | Biomarker amplification by serum carrier protein binding | |
Meier et al. | Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis | |
González-Buitrago et al. | Urinary proteomics | |
Moritz et al. | S‐Pyridylethylation of intact polyacrylamide gels and in situ digestion of electrophoretically separated proteins: A rapid mass spectrometric method for identifying cysteine‐containing peptides | |
Hinerfeld et al. | Serum/Plasma depletion with chicken immunoglobulin Y antibodies for proteomic analysis from multiple Mammalian species | |
US9417218B2 (en) | Depletion of plasma proteins | |
Flanagan et al. | Calmodulin-binding proteins: visualization by 125I-calmodulin overlay on blots quenched with Tween 20 or bovine serum albumin and poly (ethylene oxide) | |
Zhan et al. | A reference map of a human pituitary adenoma proteome | |
CA2733357A1 (en) | Healthy kidney biomarkers | |
Pretzer et al. | Saturation fluorescence labeling of proteins for proteomic analyses | |
WO2007027561A2 (en) | Systems and methods for fractionation of protein mixtures | |
Marshall et al. | Clinical analysis of human urinary proteins using high resolution electrophoretic methods | |
JPH06502912A (en) | Analyte variant analysis | |
García-Descalzo et al. | Gel electrophoresis of proteins | |
WO2003014737A1 (en) | Quantification of low molecular weight and low abundance proteins using high resolution two-dimensional electrophoresis and mass spectrometry | |
Clark et al. | Differential diagnosis of gammopathies by capillary electrophoresis and immunosubtraction: analysis of serum samples problematic by agarose gel electrophoresis | |
Hsi et al. | A general approach for characterizing glycosylation sites of glycoproteins | |
Léger et al. | Solid-phase hexapeptide ligand libraries open up new perspectives in the discovery of biomarkers in human plasma | |
Ndao | Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI–TOF) Mass Spectrometry | |
GEORGIOU | An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum | |
Di Domenico et al. | Redox proteomics in human biofluids: sample preparation, separation and immunochemical tagging for analysis of protein oxidation | |
Sigdel et al. | Fractionation of soluble proteins in Escherichia coli using DEAE-, SP-, and phenyl sepharose chromatographies |